Novo Nordisk’s trial of semaglutide for obesity meets primary endpoint
"Novo Nordisk’s trial of semaglutide for obesity meets primary endpoint" was originally created and published by Clinical ...
clinicaltrialsarena46m
Novo Nordisk’s high-dose Wegovy increases weight loss and remains safe
Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable.
pharmaphorum23h
High-dose semaglutide ramps up weight loss, says Novo
A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity ...
The £40 weight loss jabs illegally sold on TikTok that could put you in hospital
Weight loss jabs are now are now available on the NHS for those with a prescription. But a black market for the in-demand ...
pharmaphorum20h
Sun Pharma unit poised to buy Canadian biotech Antibe
A subsidiary of Sun Pharma has reached an agreement to buy the assets of Canada's Antibe Therapeutics, a developer of drugs ...
Is running bad for your knees or is it protective? What does the research show?
On one hand, you hear people say that running can be bad for your knees over time. On the other hand, you hear that running ...
Copenhagen Post3h
MobilePay introduces fees for large transfers
MobilePay is introducing new fees for sending large amounts of money. From now on, you can send up to 4,000 DKK per recipient within 24 hours for free. If you send more than that, you’ll pay a 1% fee ...
Copenhagen Post4h
Flex job workers may receive billions after a court decision
The last Friday the Supreme Court ruled in favor of the Danish union FOA in a case against the Danish Labour Market Insurance (AES) and the Appeals Board. The decision could lead to compensation ...